Loading...
In some basic science studies, statins inhibit cancer growth through various pathways. These observations raise the following question: Could statins lower cancer- mortality? Danish researchers used national databases to address this question.
Among nearly 300,000 people who received cancer diagnoses between 1995 and 2007, 6% had used statins regularly before and after their diagnoses. During average follow-up of 3 years (but as long as 15 years in some cases), two thirds of the patients died. In analyses adjusted for several confounding variables, statin use was associated with a significant 15% drop in all-cause and cancer- deaths. Mortality reductions were noted for most cancer types (although differences did not reach statistical signifi…